How p38 MAP Kinase Helps T Cells Become Regulatory Cells
Author Information
Author(s): Huber Samuel, Schrader Jörg, Fritz Gerhard, Presser Katrin, Schmitt Steffen, Waisman Ari, Lüth Stefan, Blessing Manfred, Herkel Johannes, Schramm Christoph
Primary Institution: Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
Hypothesis
Interference with TGF-beta signaling could manipulate the peripheral generation of induced regulatory T cells (iTreg).
Conclusion
The study found that p38 MAP kinase signaling is essential for converting CD4+CD25− T cells into iTreg, suggesting it could be a therapeutic target for enhancing immunity against chronic infections or cancer.
Supporting Evidence
- Inhibition of p38 MAP kinase activity prevented the conversion of CD4+CD25− T cells into iTreg.
- The suppressive capacity of natural Treg was not affected by inhibiting p38 MAP kinase.
- Increased activation of p38 MAP kinase was observed in CD4+CD25+ T cells compared to CD4+CD25− T cells.
Takeaway
This study shows that a specific signaling pathway in T cells helps them turn into cells that can control the immune response, which is important for fighting infections and cancer.
Methodology
The researchers used murine CD4+CD25− T cells and assessed the effects of TGF-beta and p38 MAP kinase inhibitors on their conversion into iTreg in vitro.
Limitations
The study primarily used in vitro methods, which may not fully replicate in vivo conditions.
Participant Demographics
FVB/N mice, age-matched, 7 to 8 weeks old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website